Markets Gone Wild

Algernon Pharmaceuticals Appoints Netcapital Securities for Regulation A Offering Vancouver, British Columbia, March 06, 2025 – Algernon Pharmaceuticals Inc. (AGN Pharma), a Canadian clinical-stage pharmaceutical development company, has made an important announcement regarding its subsidiary, Algernon NeuroScience (AGN Neuro.) Appointment of Netcapital Securities AGN Pharma is pleased to share that it has appointed Netcapital Securities…

Feeling Sluggish: A Look at US Indices What’s Going On? So, I’ve been keeping a close eye on the US indices here at FX Empire, and let me tell you, they’re looking pretty sluggish. The initial reaction to the Non-Farm Payroll announcement was definitely lackluster. But hey, before you start panicking, let’s not forget that…

Mattel’s Surprise Profit Forecast: A Beacon of Hope Amidst Tariff Woes In an unexpected turn of events, Mattel Inc., the renowned toy manufacturer, reported a rosier-than-anticipated outlook for its fiscal year 2021 adjusting earnings per share (EPS), sending its shares soaring in after-hours trading on Tuesday. The company’s announcement came amidst the looming threat of…

Delving Deeper into Koppers’ Q4 Performance: A Closer Look at Key Metrics While the headline numbers for Koppers (KOP) may give investors a general sense of how the business fared during the quarter ended December 2024, it’s essential to explore the company’s key performance indicators in more detail. In this blog post, we’ll compare some…

Investors Encouraged to Lead Securities Fraud Class Action Lawsuit Against GitLab Inc. LOS ANGELES, Oct. 1, 2024 /PRNewswire/ — Opportunity for Lead Plaintiffs Glancy Prongay & Murray LLP (“GPM”) has announced that investors who have suffered substantial losses now have the opportunity to lead the securities fraud class action lawsuit against GitLab Inc. (“GitLab” or…